We are live on ! Find out more
TGA

TPG GP A Portfolio holdings

AUM $3.68B
1-Year Est. Return 14.99%
This Fund
S&P 500
This Quarter Est. Return
-12.51%
1 Year Est. Return
+14.99%
3 Year Est. Return
+76.26%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.47B
AUM Growth
-$1.62B
Cap. Flow
+$70.4M
Cap. Flow %
1.09%
Top 10 Hldgs %
69.23%
Holding
42
New
–
Increased
14
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
LW icon
Lamb Weston
LW
+$134M
2
ROST icon
Ross Stores
ROST
+$103M
3
TRI icon
Thomson Reuters
TRI
+$40.7M
4
MSFT icon
Microsoft
MSFT
+$34.6M
5
FWONK icon
Liberty Media Series C
FWONK
+$32.5M

Top Sells

Rank Stock Value
1
PLAN
Anaplan, Inc.
PLAN
+$210M
2
MSP
Datto Holding Corp.
MSP
+$60.1M
3
CWK icon
Cushman & Wakefield Ltd
CWK
+$51.4M
4
ELV icon
Elevance Health
ELV
+$41.7M
5
MPLX icon
MPLX
MPLX
+$9.09M

Sector Composition

Rank Sector Weight
1 Healthcare 39.65%
2 Technology 17.38%
3 Consumer Discretionary 13.31%
4 Real Estate 9.19%
5 Communication Services 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRX icon
26
Amneal Pharmaceuticals
AMRX
$5.78B
$51.6M 0.8%
16,213,367
– –
FWONA icon
27
Liberty Media Series A
FWONA
$22.8B
$45.2M 0.7%
813,719
+153,428
+23% +$8.51M
MPLX icon
28
MPLX
MPLX
$57.3B
$41.7M 0.64%
1,430,217
-283,949
-17% -$9.09M
SONY icon
29
Sony
SONY
$123B
$28.9M 0.45%
1,769,850
-32,640
-2% -$578K
NRDY icon
30
Nerdy
NRDY
$105M
$28.2M 0.44%
13,223,250
– –
RLYB icon
31
Rallybio
RLYB
$89.7M
$22.9M 0.35%
378,552
– –
VCSA
32
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$12.3M 0.19%
213,792
– –
TRVI icon
33
Trevi Therapeutics
TRVI
$2.38B
$12.2M 0.19%
4,324,883
-500,000
-10% -$1.23M
STSA
34
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$7.81M 0.12%
1,885,939
– –
FUSN
35
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$6.35M 0.1%
2,551,794
– –
UXIN
36
Uxin Ltd
UXIN
$335M
$4.93M 0.08%
117,331
+50,221
+75% +$3.01M
ETTX
37
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$2.25M 0.03%
1,020,748
– –
FERG icon
38
Ferguson
FERG
$44.4B
$348K 0.01%
3,144
– –
RPID icon
39
Rapid Micro Biosystems
RPID
$103M
$206K ﹤0.01%
47,935
– –
NRDY.WS
40
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$150K ﹤0.01%
500,000
– –
MSP
41
DELISTED
Datto Holding Corp.
MSP
– –
-2,249,524
Closed -$60.1M
PLAN
42
DELISTED
Anaplan, Inc.
PLAN
– –
-3,230,615
Closed -$210M
1
2

Similar funds

SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
EPIM
Evelyn Partners Investment Management London $3.68B AUM 21.15% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
MTIM
Marathon Trading Investment Management Radnor, Pennsylvania $3.67B AUM 21.97% 1-Year Est. Return
CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $3.66B AUM 25.21% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

TPG GP A's Q2 2022 Portfolio in Review

As of Q2 2022, TPG GP A held 42 positions worth $6.47B, down 20% from $8.09B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 4.8%. TPG GP A opened no new positions and exited 2, leaving the 42-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 42% a quarter earlier, followed by Technology and Consumer Discretionary.

  • TPG GP A added most to Lamb Weston in Q2 2022, an estimated $134M increase.
  • TPG GP A's biggest Q2 2022 reduction was Cushman & Wakefield Ltd, cutting an estimated $51.4M.
  • TPG GP A fully exited Anaplan, Inc. in Q2 2022, selling an estimated $210M.
  • TPG GP A's ten largest holdings make up 69% of its $6.47B portfolio in Q2 2022.
  • TPG GP A opened 0 new positions and closed 2 in Q2 2022.
  • TPG GP A's portfolio value fell 20% quarter-over-quarter to $6.47B.

Based on TPG GP A's 13F filing for Q2 2022, filed 15 Aug 2022.